Tickers

1. Composite Trajectory Verdict

Given FIGS's direct-to-consumer apparel model with high gross margins, no debt, and inventory-driven working capital, the income statement and cash flow statement carry the most weight for assessing financial performance, as they reveal the core profitability and cash conversion dynamics of the business.

Composite Trajectory: Mixed

Annual results show a divergent picture: revenue and net income improved sharply in FY2025 (revenue +13.6% to $631.1M, net income +1160% to $34.3M), but gross margin contracted for the second consecutive year (69.1% → 67.6% → 66.5%) and operating cash flow declined for the second straight year ($100.9M → $81.2M → $61.2M). The balance sheet strengthened with cash and short-term investments rising to $300.9M at December 2025 and equity growing to $437.5M. Quarterly data for H1 2026 shows a sharp inflection: revenue +28.5% YTD, gross margin expansion of 450 bps to 71.8%, net income margin of 9.7% vs 2.5%, and operating cash flow of $43.7M vs -$3.2M. The annual trend is mixed (profit up, cash down, margin down); the recent quarterly trend is strongly improving. The composite is Mixed because the annual cash flow deterioration and margin compression offset the earnings recovery, even as the latest quarterly data signals a potential turnaround.

2. Red Flags

• Operating cash flow declined for two consecutive years while net income rose sharply: FY2025 operating cash flow $61.2M vs $81.2M in FY2024 (-$20.0M) despite net income increasing $31.5M YoY (10-K FY2025, Consolidated Statements of Cash Flows).
• Gross margin compressed for two straight years despite revenue growth: 69.1% (FY2023) → 67.6% (FY2024) → 66.5% (FY2025), a cumulative 260 bps decline (10-K FY2025, Consolidated Statements of Operations).
• Accrued expenses dropped from $42.3M to $20.5M at December 31, 2025, with the MD&A attributing a $55.2M cash outflow to "timing of cash payments related to accrued expenses" (10-K FY2025, MD&A Liquidity and Capital Resources).
• CBP Withhold Release Order on Jordanian manufacturer (~1/3 of finished goods production in Q2 2026) expected to "adversely impact net revenues, gross margin and inventory levels in the second half of 2026" (10-Q Q2 2026, MD&A Recent Developments).
• $16.0M IEEPA tariff refund receivable recorded at June 30, 2026, with uncertainty on Phase II timing and collectability (10-Q Q2 2026, Note 5).
• Share repurchases accelerated to $32.8M in H1 2026 vs $2.7M in all of FY2025, reducing cash and additional paid-in capital (10-Q Q2 2026, MD&A Liquidity and Capital Resources).
• Effective tax rates remained elevated at 81.0% (FY2024) and 44.5% (FY2023) due to permanent disallowance of stock-based compensation, though improved to 27.4% in FY2025 (10-K FY2025, Note 12).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

FY2025 net revenues grew 13.6% to $631.1M from $555.6M, driven by active customer growth (+9.4% to 2.9M) and higher AOV ($120 vs $113). Net income surged to $34.3M from $2.7M, expanding net income margin to 5.4% from 0.5%. However, gross margin fell 110 bps to 66.5%, the second consecutive annual decline (FY2023: 69.1%), primarily due to tariff impacts (-120 bps) and inventory write-offs. Operating expenses as a percentage of revenue improved to 60.5% from 67.2% on leverage from higher revenue. Quarterly H1 2026 shows strong improvement: revenue +28.5% to $356.5M, gross margin +450 bps to 71.8% (aided by $15.4M IEEPA refunds), and net income margin of 9.7% vs 2.5% in H1 2025. The annual series is mixed (top-line and bottom-line growth offset by margin erosion); the quarterly series is improving.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Annual operating cash flow declined for two consecutive years: $100.9M (FY2023) → $81.2M (FY2024) → $61.2M (FY2025). Free cash flow followed the same pattern: ~$84.6M → $64.1M → $53.0M. The FY2025 decline was driven by a $55.2M cash outflow from accrued expenses timing, $15.5M higher inventory purchases, and $3.1M from deferred revenue timing, partially offset by higher net income and favorable working capital movements elsewhere. In contrast, H1 2026 operating cash flow jumped to $43.7M from -$3.2M in H1 2025, and free cash flow to $38.6M from -$5.6M, driven by higher net income (including IEEPA refund benefit), lower inventory purchases ($28.2M less), and $38.6M favorable accrued expenses timing. The annual trend is deteriorating; the most recent semi-annual period shows a sharp reversal, but the two-year annual downtrend dominates the annual trajectory assessment.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

Total cash and short-term investments increased from $245.1M (Dec 2024: $85.6M cash + $159.5M ST investments) to $300.9M (Dec 2025: $82.0M + $218.9M) to $296.3M (Jun 2026: $108.5M + $187.8M). Total equity grew from $377.1M to $437.5M to $442.4M over the same periods. The company maintains zero outstanding borrowings on its $100M revolving credit facility (only $8.4M letters of credit). Inventory peaked at $128.0M in Dec 2025 but declined to $119.6M by Jun 2026, while inventory purchase obligations fell from $73.4M to $63.1M. Current liabilities remained stable near $90-91M. No debt maturities or leverage concerns exist. The balance sheet has strengthened consistently across both annual and quarterly periods.

6. Data Gaps

• FY2023 short-term investments balance (10-K balance sheet only shows FY2024 and FY2025; cash flow statement shows beginning cash but not ST investments)
• FY2023 free cash flow (capex known at $16.3M from cash flow statement, but change in ST investments unknown)
• Standalone Q1 2026 income statement and cash flow figures (10-Q for Q2 2026 only provides YTD and Q2 columns)
• Full-year FY2026 results (only six months available through Q2 2026 10-Q)
• Inventory turnover days for each period (not directly disclosed)
• Detailed breakdown of "accrued expenses" components for FY2023 (Note 8 only provides FY2024 and FY2025 detail)